Workflow
LIFR - STAT3信号轴
icon
Search documents
"中年膨胀"的背后:一场蓄谋已久的脂肪细胞叛乱
GLP1减重宝典· 2025-10-16 14:05
Core Insights - The article discusses the phenomenon of "middle-aged expansion," attributing it to a unique activation of adipose progenitor cells (APCs) that occurs with aging, leading to increased visceral fat accumulation [5][6][8]. Group 1: Mechanism of Middle-Aged Weight Gain - A joint study by the City of Hope Medical Center and UCLA reveals that the abnormal accumulation of visceral fat in middle age is driven by a specific type of adipose stem cell that becomes active as people age [6][11]. - The research indicates that even with unchanged diet and exercise habits, middle-aged individuals may still experience weight gain due to these activated stem cells, which proliferate uncontrollably [6][8]. - The study highlights that the increase in fat cells is not merely a result of excess caloric intake but is linked to a programmed change in the adipose stem cells themselves [8][10]. Group 2: Identification of Key Cell Types - Researchers identified a specific subgroup of adipose progenitor cells, termed CP-A cells, which significantly increase in number with age and are responsible for the heightened fat cell production in middle-aged mice [10][11]. - The presence of CP-A-like cells was also confirmed in human male perivisceral fat tissue, showing a positive correlation with age [10]. Group 3: Signaling Pathways and Therapeutic Implications - The study pinpointed the LIFR-STAT3 signaling axis as a central mechanism driving the excessive fat generation in CP-A cells, with elevated expression of leukemia inhibitory factor receptor (LIFR) leading to increased adipogenesis [11]. - Treatment with LIFR or STAT3 inhibitors effectively reduced the adipogenic capacity of CP-A cells, suggesting potential therapeutic strategies for combating age-related obesity [11]. - The findings provide a new understanding of the biological mechanisms behind middle-aged weight gain and open avenues for targeted anti-obesity therapies [11].